Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis
Diabetes · 01.10.2025 · 74 (10) · 1802-1813
DOI: 10.2337/db25-0077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 15.08.2025. Verfasst von Yueqi Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Diabetic Cardiomyopathies, Protein C, Cellular Senescence. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation Program of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DbCM) is a chronic metabolic disorder with few effective treatment strategies. Our previous study demonstrated that activated protein C (aPC), a serine protease, exerts cytoprotective effects in DbCM. However, the mechanisms underlying its role in DbCM require further elucidation. We developed a type 1 diabetic mouse model using thrombomodulin gene point mutation mice (TMP/P) with reduced endogenous aPC generation and investigated the protective effects of aPC on DbCM through intraperitoneal injection of PC. Myocardial functions and structure were assessed by echocardiography and histology. Transcriptomic analysis and immunological evaluation were conducted to investigate the downstream targets. The antisenescence role of aPC was reaffirmed by PC treatment in vivo and aPC intervention in cultured neonatal rat ventricular myocytes in vitro. Endogenous aPC levels were reduced and positively correlated with cardiac diastolic function in diabetic mice. Cardiomyocytes manifested a senescent phenotype in DbCM. With impaired aPC activation, TMP/P mice exhibited aggravated diabetes-induced cardiac dysfunction and cardiomyocyte senescence. Mechanistically, aPC alleviated cardiomyocyte senescence in DbCM by acting on PAR1/PAR3 to restore the interaction between P85 and CaMKIIδ, thereby inhibiting CaMKIIδ phosphorylation and its nuclear translocation. In summary, our study highlights that aPC ameliorates cardiomyocyte senescence in DbCM via the PAR1/PAR3-P85-CaMKIIδ axis. Article Highlights Diabetes exacerbates cardiomyocyte senescence, leading to an accelerated decline in cardiac function. The systemic levels of activated protein C (aPC) were reduced, which correlated with deterioration of cardiac diastolic function in diabetic cardiomyopathy (DbCM), while the underlying mechanisms remained unclear. We aim to identify the role of aPC in ameliorating cardiomyocyte senescence in DbCM. We highlighted that aPC ameliorated cardiomyocyte senescence in DbCM via the PAR1/PAR3-P85-CaMKIIδ axis with genetic (TMP/P) and interventional (PC injection) diabetic mouse models. These findings could lead to increased insight into the pathogenesis and innovative therapeutic approaches of diabetic cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, Hubei, China.
- Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Sports Biology and Kinesiology, Faculty of Sciences, University of Pécs, Pécs, Hungary.
- ELKH-PTE PACAP Research Team, Department of Anatomy, Medical School, University of Pécs, Pécs, Hungary.
- Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
ORCID-Profile: Chang Xu, Hongjie Wang, Hesong Zeng
Förderung
- Natural Science Foundation Program of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Dai, L., Wang, M., Zhong, X., Liu, X., Zhang, K., Luo, L., Wang, L., Dong, W., Vaczy, A., Li, L., Atlasz, T., Madhusudhan, T., Xu, C., Wang, H., & Zeng, H. (2025). Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis. Diabetes, 74(10), 1802-1813. https://doi.org/10.2337/db25-0077
Vancouver
Zhang Y, Dai L, Wang M, Zhong X, Liu X, Zhang K, et al. Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis. Diabetes. 2025;74(10):1802-1813. doi:10.2337/db25-0077
BibTeX
@article{Zhang2025,
author = {Zhang, Yueqi and Dai, Lei and Wang, Mengwen and Zhong, Xiaodan and Liu, Xiaolei and Zhang, Kaiyue and Luo, Lingyun and Wang, Lingyun and Dong, Wei and Vaczy, Alexandra and Li, Lina and Atlasz, Tamas and Madhusudhan, Thati and Xu, Chang and Wang, Hongjie and Zeng, Hesong},
title = {Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {10},
pages = {1802--1813},
doi = {10.2337/db25-0077}
}
EUVIMED